|
|
Volumn 326, Issue 7389, 2003, Pages 565-
|
|
FDA officials argue over safety of new arthritis drug.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ISOXAZOLE DERIVATIVE;
LEFLUNOMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ARTICLE;
DRUG CONTROL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
RHEUMATOID ARTHRITIS;
UNITED STATES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
DRUG AND NARCOTIC CONTROL;
HUMANS;
ISOXAZOLES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 0037445259
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.326.7389.565/a Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
